These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26227494)

  • 1. Short-term and long-term effect of diaphragm biofeedback training in gastroesophageal reflux disease: an open-label, pilot, randomized trial.
    Sun X; Shang W; Wang Z; Liu X; Fang X; Ke M
    Dis Esophagus; 2016 Oct; 29(7):829-836. PubMed ID: 26227494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study.
    Eherer AJ; Netolitzky F; Högenauer C; Puschnig G; Hinterleitner TA; Scheidl S; Kraxner W; Krejs GJ; Hoffmann KM
    Am J Gastroenterol; 2012 Mar; 107(3):372-8. PubMed ID: 22146488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
    Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oxenberg D; Perez-Castilla A; Netto MG; Soffer E; Boscardin WJ; Crowell MD
    Surgery; 2015 Mar; 157(3):556-67. PubMed ID: 25726315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic mechanism of diaphragm training at different periods in patients with gastroesophageal reflux disease].
    Ding ZL; Wang ZF; Sun XH; Ke MY
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3215-9. PubMed ID: 24405544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of diaphragmatic crural barrier and esophageal body clearance in patients with gastroesophageal reflux disease].
    Sun XH; Ke MY; Wang ZF; Fang XC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):289-93. PubMed ID: 12905637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
    Suzuki T; Matsushima M; Masui A; Tsuda S; Imai J; Nakamura J; Tsukune Y; Uchida T; Yuhara H; Igarashi M; Koike J; Mine T
    World J Gastroenterol; 2015 Apr; 21(16):5023-31. PubMed ID: 25945018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
    Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction.
    Noar MD; Noar E
    Surg Endosc; 2008 Nov; 22(11):2440-4. PubMed ID: 18437485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center.
    Bonavina L; Saino G; Bona D; Sironi A; Lazzari V
    J Am Coll Surg; 2013 Oct; 217(4):577-85. PubMed ID: 23856355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
    Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Akahoshi T; Kawanaka H; Tomikawa M; Saeki H; Uchiyama H; Ikeda T; Shirabe K; Hashizume M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):483-9. PubMed ID: 24693675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action.
    DiBaise JK; Brand RE; Quigley EM
    Am J Gastroenterol; 2002 Apr; 97(4):833-42. PubMed ID: 12003416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophagogastric Junction Morphology and Distal Esophageal Acid Exposure.
    Akimoto S; Singhal S; Masuda T; Yamamoto SR; Svetanoff WJ; Mittal SK
    Dig Dis Sci; 2016 Dec; 61(12):3537-3544. PubMed ID: 27730315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial.
    Bonavina L; DeMeester T; Fockens P; Dunn D; Saino G; Bona D; Lipham J; Bemelman W; Ganz RA
    Ann Surg; 2010 Nov; 252(5):857-62. PubMed ID: 21037442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the pathogenesis of gastroesophageal reflux: the concept of gastroesophageal dyssynergia.
    Shafik A; Shafik I; El-Sibai O; Shafik AA
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):401-7. PubMed ID: 16077405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trial.
    Kappelle WF; Bredenoord AJ; Conchillo JM; Ruurda JP; Bouvy ND; van Berge Henegouwen MI; Chiu PW; Booth M; Hani A; Reddy DN; Bogte A; Smout AJ; Wu JC; Escalona A; Valdovinos MA; Torres-Villalobos G; Siersema PD
    Aliment Pharmacol Ther; 2015 Sep; 42(5):614-25. PubMed ID: 26153531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters.
    Velanovich V; Karmy-Jones R
    Am Surg; 1998 Jul; 64(7):649-53. PubMed ID: 9655276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of delayed release rabeprazole in 1- to 11-month-old infants with symptomatic GERD.
    Hussain S; Kierkus J; Hu P; Hoffman D; Lekich R; Sloan S; Treem W
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):226-36. PubMed ID: 24121146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.